Jun 05, 2023 7:00am EDT NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
Jun 01, 2023 7:00am EDT NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
May 30, 2023 7:00am EDT NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO